Financhill
Back

Avid Bioservices 10K Form

Buy
60

CDMO
Avid Bioservices

Last Price:
8.23
Seasonality Move:
18.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CDMO News And Ratings

See the #1 stock for the next 7 days that we like better than CDMO

CDMO Financial Statistics

Sales & Book Value

Annual Sales: $149.27M
Cash Flow: $-801K
Price / Cash Flow: 0
Annual Sales: $2.84
Price / Book: 2.91

Profitability

EPS (TTM): -0.27490
Net Income (TTM): $-17.68M
Gross Margin: $31.48M
Return on Equity: -9.51%
Return on Assets: -3.92%

Avid Bioservices Earnings Forecast

Key Avid Bioservices Financial Ratios

  • The Gross Profit Margin over the past 29 years for CDMO is 21.09%.
  • The Selling, General & Administrative Expenses for CDMO have been equal to 18.68% of Gross Profit Margin.
  • The Research & Development expenses have been 49.11% of Revenue.
  • The Interest Expense is 464.29% of Operating Income.
  • The Net Earning history of CDMO is 0.38% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 19 years.

Avid Bioservices Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CDMO
CUSIP: 05368M
Website: avidbio.com

Debt

Debt-to-Equity Ratio: 0.78
Current Ratio: 0.46
Quick Ratio: 0.28

Price-to-Earnings

Trailing P/E Ratio: 825
Forward P/E Ratio: 43.42

CDMO Technical Analysis vs Fundamental Analysis

Buy
60
Avid Bioservices (CDMO) is a Buy

Is Avid Bioservices a Buy or a Sell?

  • Avid Bioservices stock is rated a Buy
    The current Avid Bioservices [CDMO] share price is $8.25. The Score for CDMO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.